Hyperlipidemia prediction on Hall
25PR-AUCMantisV2
Evaluation results
| Method | Links | |||
|---|---|---|---|---|
| MantisV2Params=4.2M, Evaluation Protocol=Linear-probe2026.05 | 25 | 58.8 | 52.6 | |
| MantisParams=8M, Evaluation Protocol=Linear-probe2026.05 | 24.8 | 57.9 | 53.7 | |
| Chronos-2 (small)Params=28M, Evaluation Protocol=Linear-probe2026.05 | 24.2 | 61.3 | 52.5 | |
| GluFormer (tiny)Params=0.65M, Evaluation Protocol=Linear-probe2026.05 | 21.6 | 58 | 53.1 | |
| Chronos-2Params=120M, Evaluation Protocol=Linear-probe2026.05 | 20.6 | 50.3 | 50.9 | |
| MOMENT (small)Params=40M, Evaluation Protocol=Linear-probe2026.05 | 19.4 | 48.7 | 50.4 | |
| MOMENT (large)Params=385M, Evaluation Protocol=Linear-probe2026.05 | 18.4 | 51.4 | 47.7 | |
| CGMformerParams=0.85M, Evaluation Protocol=Linear-probe2026.05 | 18 | 46.5 | 48.4 | |
| X-CGM-JEPAParams=0.52M, Evaluation Protocol=Linear-probe2026.05 | 17.5 | 40 | 42.8 | |
| CGM-JEPAParams=0.52M, Evaluation Protocol=Linear-probe2026.05 | 17.3 | 40.5 | 42.8 | |
| GluFormer (base)Params=135M, Evaluation Protocol=Linear-probe2026.05 | 16.4 | 46.9 | 47.7 | |
| GlucoFMParams=0.72M, Evaluation Protocol=Linear-probe2026.05 | 14.4 | 41.6 | 43.1 |